In Russia, approximately 54 percent of new cancer cases are diagnosed in women, as reported by Andrey Kaprin, the Chief Oncologist of the Russian Ministry of Health. The average age of patients at the time of diagnosis is 65 years, indicating a prevalence of oncological diseases within older age groups. This gender distribution, where women account for 54% and men for 46% of new cases, has remained notably stable over the past decade.
A significant advancement in patient care is the inclusion of modern treatment methods and support for oncology patients within Russia’s mandatory medical insurance (OMS) program. Under OMS, patients can now access treatments utilizing Russian oncological vaccines, including personalized versions specifically tailored to stimulate a patient’s immune system to combat tumors effectively. Andrey Kaprin further highlighted that a Russian-developed mRNA cancer vaccine will also be made available to patients completely free of charge.
